Cargando…

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials

Pancreatic cancer is rising as one of the leading causes of cancer-related death worldwide. Patients often present with advanced disease, limiting curative treatment options and therefore making management of the disease difficult. Systemic chemotherapy has been an established part of the standard t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ejlsmark, Mathilde Weisz, Schytte, Tine, Bernchou, Uffe, Bahij, Rana, Weber, Britta, Mortensen, Michael Bau, Pfeiffer, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378124/ https://www.ncbi.nlm.nih.gov/pubmed/37504359 http://dx.doi.org/10.3390/curroncol30070499

Ejemplares similares

The effect of respiration-induced target motion on 3D magnetic resonance images used to guide radiotherapy
por: Bertelsen, Anders, et al.
Publicado: (2022)

Tumor-site specific geometric distortions in high field integrated magnetic resonance linear accelerator radiotherapy
por: Hasler, Signe Winther, et al.
Publicado: (2020)

Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy
por: Møller, P. K., et al.
Publicado: (2021)

Correction to: Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy
por: Møller, P. K., et al.
Publicado: (2021)

Feasibility, usability and acceptance of weekly electronic patient-reported outcomes among patients receiving pelvic CT- or online MR-guided radiotherapy – A prospective pilot study
por: Møller, P.K., et al.
Publicado: (2021)

An open-source nnU-net algorithm for automatic segmentation of MRI scans in the male pelvis for adaptive radiotherapy
por: Lorenzen, Ebbe Laugaard, et al.
Publicado: (2023)

Accuracy of automatic deformable structure propagation for high-field MRI guided prostate radiotherapy
por: Christiansen, Rasmus Lübeck, et al.
Publicado: (2020)

Plan quality for high-risk prostate cancer treated with high field magnetic resonance imaging guided radiotherapy
por: Christiansen, Rasmus Lübeck, et al.
Publicado: (2018)

First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
por: Janssen, Tomas M., et al.
Publicado: (2022)

Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review
por: Ploug, Magnus, et al.
Publicado: (2020)

Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC
por: Nielsen, Malene, et al.
Publicado: (2021)

Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
por: Ng, Sylvia S. W., et al.
Publicado: (2022)

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients – study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study
por: Graversen, Martin, et al.
Publicado: (2018)

Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations
por: Nielsen, Michael Friberg Bruun, et al.
Publicado: (2018)

Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patients
por: Kim, Carolyn H, et al.
Publicado: (2013)

The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
por: Wu, Linxia, et al.
Publicado: (2022)

Robust extraction of biological information from diffusion-weighted magnetic resonance imaging during radiotherapy using semi-automatic delineation
por: Bisgaard, Anne Louise Højmark, et al.
Publicado: (2022)

Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis
por: Graversen, Martin, et al.
Publicado: (2018)

Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy – PIPAC-OPC2
por: Graversen, Martin, et al.
Publicado: (2018)

Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma
por: Liu, Xian, et al.
Publicado: (2016)

Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy
por: Jan, I-Shiow, et al.
Publicado: (2023)

PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
por: Azad, Abul, et al.
Publicado: (2016)

Use of radiotherapy in patients with palliative double bypass for locally advanced pancreatic adenocarcinoma
por: Glinka, Juan, et al.
Publicado: (2018)

Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review
por: Buwenge, Milly, et al.
Publicado: (2022)

Prognostic Significance of Initial Absolute Lymphocyte Count in Adjuvant Radiotherapy for Pancreatic Adenocarcinoma
por: Heo, Jaesung, et al.
Publicado: (2022)

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma
por: Maximous, Doaa W, et al.
Publicado: (2009)

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015)

Krüppel-like Factor 10 as a Prognostic and Predictive Biomarker of Radiotherapy in Pancreatic Adenocarcinoma
por: Tsai, Yi-Chih, et al.
Publicado: (2023)

Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma
por: Webking, Samantha, et al.
Publicado: (2023)

Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Palam, L R, et al.
Publicado: (2015)

Actin gamma 1 is a critical regulator of pancreatic ductal adenocarcinoma
por: Tang, Yichen, et al.
Publicado: (2021)

Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19
por: Spiers, H.V., et al.
Publicado: (2022)

Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT
por: Pan, Yi, et al.
Publicado: (2015)

Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation
por: McDonald, Brigid A., et al.
Publicado: (2023)

Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma
por: Lu, Yuanxiang, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical Consideration
por: Burkoň, Petr, et al.
Publicado: (2022)

Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
por: Wang, Dan, et al.
Publicado: (2020)

Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
por: Gkika, E., et al.
Publicado: (2023)

Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline
por: Biagi, James J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_drrnj6ld1l2okfho8a8hvm12cu